Hydromorphone Hydrochloride 00409-1312-36
- Manufacturer
- Hospira, Inc.
- Dosage Form
- Injection, Solution
- Route
- Intramuscular, Intravenous, And Subcutaneous
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- February 1, 2021
- Listing Expires
- December 31, 2027
- Application
- NDA200403
Active Ingredients
| Ingredient | Strength |
|---|---|
| Hydromorphone Hydrochloride | 2 mg/mL |
Drug Class
Full Opioid Agonists [MoA]Opioid Agonist [EPC]
Selected Package
00409-1312-36Selected10 SYRINGE in 1 CELLO PACK (0409-1312-36) / 1 mL in 1 SYRINGE (0409-1312-16)